Eloisi Caldas Lopes

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas

Leandro Cerchietti, Eloisi Caldas Lopes, Shao Ning Yang et al. · Nature Medicine · 2009 · 156 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +7

Kaiso Contributes to DNA Methylation-Dependent Silencing of Tumor Suppressor Genes in Colon Cancer Cell Lines

Eloisi Caldas Lopes, Ester Valls, María E. Figueroa et al. · Cancer Research · 2008 · 125 citations

Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines

Mariana Garcı́a, Laura Alaniz, Eloisi Caldas Lopes et al. · Leukemia Research · 2005 · 91 citations

Nf-κb Activity, Cancer Immunosurveillance, Medicine +9

Pre‐clinical efficacy of PU‐H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma

Srikanth Ambati, Eloisi Caldas Lopes, Kohji Kosugi et al. · Molecular Oncology · 2013 · 54 citations · Full text

Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia

Juanita Bustamante, Eloisi Caldas Lopes, Mariana Garcı́a et al. · Toxicology and Applied Pharmacology · 2004 · 36 citations

Mitochondrial Function, Psc 833, Apoptosis +7